腹膜透析患者併作血液透析成效探討

Effectiveness of Combined Therapy of Peritoneal Dialysis and Hemodialysis

林鳳如(Feng-Ju Lin) ； 吳明儒(Ming-Ju Wu) ； 陳呈旭(Cheng-Hsu Chen) ； 翁碩駿(Shuo-Chun Weng)

《腎臟與透析》 31卷1期 (2019/03) Pp. 42-47

https://doi.org/10.6340/KD.201903_31(1).0010

摘要

腹膜透析患者隨著透析年限的增長，患者面臨到殘餘腎臟功能的衰退或是感染的侵襲下造成腹膜功能損害，進而導致毒素清除率不夠或水分移除不足等窘境發生；此外患者可能會有心肺血管病變產生，大幅提升猝死的機率。因此如何提高患者的足量透析顯得更重要。實施腹膜透析併作血液透析治療，可增加毒素與水分的清除，根據本醫學中心20位患者的腹膜透析併作血液透析治療經驗，長期追蹤下還伴隨著血色素提升、鐵蛋白與血清磷降低。

關鍵字

腹膜透析 ； 血液透析 ； 血色素 ； 鐵蛋白 ； 血清磷

並列摘要

With an increase in the duration of dialysis, patients on peritoneal dialysis experience deterioration of remaining renal function or impaired peritoneal function due to infection, which subsequently leads to complications such as insufficient toxin clearance or insufficient water elimination. In addition, patients may develop cardiopulmonary vasculopathy, which greatly increases the chance of sudden death. Therefore, it is important to improve patients' dialysis adequacy. Combined peritoneal dialysis and hemodialysis can increase toxin and water clearance. The treatment experience of combined peritoneal dialysis and hemodialysis on long-term follow-up in 20 patients in our medical center revealed that the treatment results were accompanied by an increase in hemoglobin and decrease in ferritin and serum phosphorus.

並列關鍵字

peritoneal dialysis ； hemodialysis ； hemoglobin ； ferritin ； serum phosphorus